| 2025 | Adjuvant Trastuzumab Plus Pertuzumab Versus Trastuzumab Alone in Patients Achieving Pathologic Complete Response After Chemotherapy With Trastuzumab and Pertuzumab: A Retrospective Cohort Study
| CLINICAL BREAST CANCER |
| 2024 | Characteristics and Prognosis of Breast Cancer Patients With Prior Hormone Replacement Therapy: Insights From the Korean Breast Cancer Society Registry
| JOURNAL OF BREAST CANCER |
| 2024 | Nipple-areolar complex sensory recovery based on incision placement after nipple-sparing mastectomy: a prospective nonrandomized controlled trial
| INTERNATIONAL JOURNAL OF SURGERY |
| 2024 | Capsular Contracture After Postmastectomy Radiation in Implant-Based Breast Reconstruction: Effect of Implant Pocket and Two-Stage Surgery
| JOURNAL OF BREAST CANCER |
| 2024 | Stromal tumor-infiltrating lymphocytes and pathologic response to neoadjuvant chemotherapy with the addition of platinum and pembrolizumab in TNBC: a single-center real-world study
| BREAST CANCER RESEARCH |
| 2024 | Clinical Relevance of TP53 Mutation and Its Characteristics in Breast Cancer with Long-Term Follow-Up Date
| CANCERS |
| 2024 | Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 h+HER2-breast cancer: a retrospective analysis
| BREAST CANCER RESEARCH |
| 2024 | Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy: an ASTRRA Substudy
| BREAST CANCER RESEARCH |
| 2024 | Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative
| NPJ BREAST CANCER |
| 2024 | Micrometastases in axillary lymph nodes in breast cancer, post-neoadjuvant systemic therapy
| BREAST CANCER RESEARCH |
| 2024 | Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review | FAMILIAL CANCER |
| 2024 | Loss of LPAR6 and CAB39L dysregulates the basalto-luminal urothelial differentiation program, contributing to bladder carcinogenesis
| CELL REPORTS |
| 2024 | Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates
| BREAST CANCER RESEARCH |
| 2024 | Outcomes of sentinel node biopsy according to MRI response in an association with the subtypes in cN1-3 breast cancer after neoadjuvant systemic therapy, multicenter cohort study
| BREAST CANCER RESEARCH |
| 2024 | Tumor-Infiltrating Lymphocyte Level Consistently Correlates with Lower Stiffness Measured by Shear-Wave Elastography: Subtype-Specific Analysis of Its Implication in Breast Cancer
| CANCERS |
| 2024 | Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
| YONSEI MEDICAL JOURNAL |
| 2024 | Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade
| CANCERS |
| 2024 | Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study
| INTERNATIONAL JOURNAL OF SURGERY |
| 2024 | Elasticity Values as a Predictive Modality for Response to Neoadjuvant Chemotherapy in Breast Cancer
| CANCERS |
| 2023 | Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma
| JAMA NETWORK OPEN |
| 2023 | Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial | JOURNAL OF CLINICAL ONCOLOGY |
| 2023 | Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer
| CANCER RESEARCH AND TREATMENT |
| 2023 | YAP1 Expression in HR+HER2- Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation
| CANCERS |
| 2023 | Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE |
| 2023 | Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery
| SCIENTIFIC REPORTS |
| 2023 | Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review
| JOURNAL OF BREAST CANCER |
| 2023 | Ki-67, 21-Gene Recurrence Score, Endocrine Resistance, and Survival in Patients With Breast Cancer
| JAMA NETWORK OPEN |
| 2023 | Comparison of Programmed Cell Death Ligand 1 Status between Core Needle Biopsy and Surgical Specimens of Triple-Negative Breast Cancer
| YONSEI MEDICAL JOURNAL |
| 2023 | Predictive biological factors for late survival in patients with HER2-positive breast cancer
| SCIENTIFIC REPORTS |
| 2023 | Radiation dose-event relationship after intraoperative radiotherapy as a boost in patients with breast cancer
| FRONTIERS IN ONCOLOGY |
| 2023 | Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1-2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapy
| FRONTIERS IN ONCOLOGY |
| 2023 | Resolution of Nonmass Enhancement Extension to the Nipple at Breast MRI after Neoadjuvant Chemotherapy: Pathologic Response and Feasibility for Nipple-sparing Mastectomy | RADIOLOGY |
| 2023 | Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination
| MOLECULAR CANCER |
| 2023 | Complications Including Capsular Contracture in Direct-to-Implant Breast Reconstruction With Textured Anatomical Versus Smooth Round Implants: A Single Center Retrospective Analysis
| JOURNAL OF BREAST CANCER |
| 2023 | On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates
| BREAST CANCER RESEARCH |
| 2023 | Shear-wave elastography-based nomograms predicting 21-gene recurrence score for adjuvant chemotherapy decisions in patients with breast cancer | EUROPEAN JOURNAL OF RADIOLOGY |
| 2023 | Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP
| CANCER MEDICINE |
| 2022 | Survival benefit from axillary surgery in patients aged 70 years or older with clinically node-negative breast cancer: A population-based propensity-score matched analysis | EJSO |
| 2022 | Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
| JOURNAL OF BREAST CANCER |
| 2022 | 18F-FDG uptake of visceral adipose tissue on preoperative PET/CT as a predictive marker for breast cancer recurrence
| SCIENTIFIC REPORTS |
| 2022 | Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor-Positive, ERBB2-Negative Breast Cancer
| JAMA NETWORK OPEN |
| 2022 | Correlation of Yes-Associated Protein 1 with Stroma Type and Tumor Stiffness in Hormone-Receptor Positive Breast Cancer
| CANCERS |
| 2022 | Residual Tumor Patterns of Breast Cancer on MRI after Neo-Adjuvant Chemotherapy: Impact on Clinicopathologic Factors and Prognosis
| DIAGNOSTICS |
| 2022 | Blood Test for Breast Cancer Screening through the Detection of Tumor-Associated Circulating Transcripts
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2022 | CD39+ tissue-resident memory CD8+ T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer | SCIENCE IMMUNOLOGY |
| 2022 | The Risk Factors, Incidence and Prognosis of Postpartum Breast Cancer: A Nationwide Study by the SMARTSHIP Group
| FRONTIERS IN ONCOLOGY |
| 2022 | Effects of Single Nucleotide Polymorphisms and Mediterranean Diet in Overweight or Obese Postmenopausal Women With Breast Cancer Receiving Adjuvant Hormone Therapy: A Pilot Randomized Controlled Trial
| FRONTIERS IN NUTRITION |
| 2022 | RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis | BREAST CANCER RESEARCH AND TREATMENT |
| 2022 | Low incidence of lymph node metastasis in patients with microinvasive breast cancer: a Korean nationwide study
| ANNALS OF SURGICAL TREATMENT AND RESEARCH |
| 2022 | SP142 PD-L1 Assays in Multiple Samples from the Same Patients with Early or Advanced Triple-Negative Breast Cancer
| CANCERS |
http://orcid.org/0000-0003-0397-0005
(55184774900)
